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Mutations in the zebrafish gene moonshine, encoding the ortholog of TIF1g, cause profound anemia
and embryonic lethality. In a recent issue of Cell, Bai et al. provide evidence that these defects arise from
inefficient transcription elongation, implicating elongation as an important point of regulation during cell
differentiation and development.Development depends critically upon the
establishment and maintenance of tis-
sue-specific gene expression programs.
Although much is known about the sig-
naling pathways and transcription factors
that influence cell fate decisions, the
mechanisms underlying the precise tem-
poral and spatial regulation of transcrip-
tion during development remain unclear.
One paradigm for understanding the
differentiation of multipotent, self-renew-
ing stem cells into lineage-committed
cells is hematopoiesis. This process is
conserved throughout vertebrate evolu-
tion, and the events that program hemato-
poietic stem cells to undergo lineage-
restricted differentiation have been the
subject of extensive research. Recently,
work by Bai et al. (2010), published in
Cell, sheds new light on the changes in
gene expression that occur during eryth-
ropoiesis by revealing a decisive role for
regulated transcription elongation.
This exciting finding comes on the heels
of work indicating that transcription elon-
gation is highly regulated during develop-
ment (Nechaev and Adelman, 2008). In
particular, promoter-proximal pausing of
RNA polymerase II (Pol II) was recently
shown to be widespread across meta-
zoan genomes (Core et al., 2008; Ne-
chaev and Adelman, 2008). Pausing
occurs shortly after transcription initia-
tion, when Pol II comes under the influ-
ence of negative transcription factors
such as DSIF (DRB sensitivity-inducing
factor). DSIF, comprised of Spt4 and
Spt5 proteins, plays dual roles in tran-
scription elongation: DSIF inhibits early
elongation by inducing pausing but stimu-
lates productive transcript synthesis
further downstream (Price, 2008). Thisswitch in DSIF activity and the release of
paused Pol II into productive elongation
is triggered by the recruitment of the
P-TEFb (positive transcription elongation
factor b) kinase. P-TEFb rapidly stimu-
lates elongation by phosphorylating the
C-terminal domains of both Spt5 and the
largest subunit of Pol II (Price, 2008).
Paused Pol II is prevalent at developmen-
tally-regulated promoters, suggesting
that having a polymerase ‘‘waiting’’ near
the promoter might facilitate precise, syn-
chronous expression of developmental
genes (Boettiger and Levine, 2009; Ne-
chaev and Adelman, 2008).
This idea is consistent with earlier stud-
ies of the murine b-globin gene cluster,
which demonstrated that the locus
control region (LCR) regulates gene acti-
vation primarily at the level of transcription
elongation (Sawado et al., 2003; Fig-
ure 1A). This pioneering work established
that although deletion of the LCR resulted
in a >90% reduction in b-globin transcript
levels, it had only a modest affect on the
recruitment of Pol II to the b-globin
promoter. Importantly, presence of the
LCR substantially increased phosphoryla-
tion of promoter-proximal Pol II and poly-
merase density within the b-globin gene,
suggesting that gene expression is
controlled through the release of paused
polymerase.
Expanding on this idea, the results in
Bai et al. (2010) implicate regulated elon-
gation in hematopoiesis from zebrafish
to humans. The researchers investigated
moonshine, a mutant zebrafish with
defects in erythroid maturation due to
deficiency of TIF1g, a key regulator of
hematopoietic gene expression (Ransom
et al., 2004). Through elegant suppressorDevelopmental Cscreens in zebrafish, they identified the
sunrise mutant, which carries a mutation
in the cdc73 gene. cdc73 is an integral
component of the Paf1 complex (Paf1C),
which functions in transcription elonga-
tion and chromatin modification. Further-
more, Bai et al. (2010) show that loss of
any subunit of Paf1C suppresses the
moonshine phenotype, conclusively dem-
onstrating a functional antagonism be-
tween Paf1C and TIF1g in erythroid gene
transcription.
Dissecting the opposing contributions
of TIF1g and Paf1C to hematopoiesis,
however, is a tricky business. Controversy
exists over the function of TIF1g, which
has been suggested to either promote or
inhibit TGF-b signaling during blood
development. Arguing that TIF1g plays a
stimulatory role, Bai et al. (2010) identified
two positive transcription elongation
factors as binding partners of TIF1g:
P-TEFb and FACT (facilitates access to
chromatin templates). Intriguingly, their
data suggest that TIF1g could release
paused Pol II by actively recruiting P-
TEFb. Moreover, FACT is known to facili-
tate elongation through chromatin, which
would further enhance elongation effi-
ciency at TIF1g target genes.
Thus, TIF1g appears to promote tran-
scription elongation. But how might the
absence of Paf1C suppress mutations in
TIF1g? To address these questions, Bai
et al. (2010) considered the myriad roles
of Paf1C, including stimulation of elonga-
tion, histone modifications, and recruit-
ment of 30-RNA processing factors. Using
additional genetic assays, Bai et al. (2010)
ruled out a need for several Paf1C-depen-
dent histone modifications and RNA pro-
cessing factors in suppression of bloodell 19, July 20, 2010 ª2010 Elsevier Inc. 9
Figure 1. The Elongation Phase of Transcription Is Highly Regulated
during Hematopoiesis
(A) Studies of the murine b-globin gene cluster have demonstrated that the
critical locus control region (LCR) is not essential for recruitment of Pol II
(red) to the b-globin promoter but that productive elongation and phosphory-
lation of Pol II (green P) require an intact LCR. This finding implicates the
transcription factor NF-E2 (brown) which binds the LCR, in delivery of
P-TEFb (green) to the b-globin promoter, and release of Pol II from pausing
mediated by DSIF (purple).
(B) A similar model is proposed for erythroid gene transcription, wherein
recruited Pol II would not efficiently transcribe blood genes in the absence of
TIF1g due to inhibition of transcription by DSIF and/or Paf1C (blue). Binding
of TIF1g and the SCL complex (orange) would stimulate release from pausing
through recruitment of P-TEFb. Notably, FACT, Paf1C, and Rpd3S would
work together both to permit transcription elongation through chromatin and
to reassemble nucleosomes over the transcribed gene, perhaps limiting
subsequent rounds of transcription elongation.
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bilities down to Paf1C’s role
in transcription elongation, or
in recruitment of the Rpd3S
histone de-acetylation com-
plex. Notably, all previous
evidence indicates that the
direct effects of Paf1C on
transcription elongation are
positive in nature and occur
well downstream from the
promoter (Kim et al., 2010),
which is seemingly at odds
with its ability to antagonize
TIF1g function.
In contrast, the indirect
effect of Paf1C on recruit-
ment of Rpd3S is generally
thought to be inhibitory, since
Rpd3S removes stimulatory
acetyl groups from histones
and helps reassemble nucle-
osomes in the wake of
elongating polymerase. Inter-
estingly, in S. cerevisiae,
mutations in a Paf1C subunit
or Rpd3S suppress growth
defects caused by defi-
ciencies in the yeast homo-
logs of P-TEFb (Bur1) orFACT (Buratowski, 2009). This raises
striking parallels with the results in Bai
et al. (2010), where loss of Paf1C sup-
presses deficiencies in TIF1g, a factor
that recruits P-TEFb and FACT. Thus,
the negative role of Paf1C on erythroid
gene transcription in sunrise mutants
may occur through manipulation of pro-
moter-proximal chromatin structure.
Bai et al. (2010) also provide support for
Pol II pausing at erythroid genes. Blood
defects in moonshine were rescued by
mutations in foggy, the zebrafish Spt5
gene. Foggy was first isolated in genetic
screens for factors that affected neuronal
development (Guo et al., 2000), and the
mutant identified caused early lethality
through deficits in blood circulation and
neuronal function. In vitro transcription10 Developmental Cell 19, July 20, 2010 ª20assays revealed that the foggy mutant
was unable to elicit Pol II pausing but
was fully functional in its stimulatory activ-
ities, thereby suggesting that pausing was
critical for early zebrafish development
(Guo et al., 2000). Accordingly, the finding
that this foggymutant suppresses defects
in moonshine argues that TIF1g does
indeed impact paused Pol II.
Thus, Bai et al. (2010) put forth the
appealingmodel that defects in themoon-
shine mutants are manifested at the level
of pausing (Figure 1B). This hypothesis
makes several important predictions that
await testing. For instance, if TIF1g is
required to overcome pausing at blood
genes, then paused Pol II should be
observed at these promoters in TIF1g-
deficient cells. Furthermore, if the loss of10 Elsevier Inc.DSIF or Paf1C relieves the
need for TIF1g to release
paused Pol II, then erythroid
genes should experience
aberrant transcription in these
mutants, prior to receiving
appropriate developmental
cues. Finally, the intriguing
negative role of Paf1C re-
mains to be elucidated. Pre-
viouswork has failed todetect
Paf1C associated with
paused Pol II (Kim et al.,
2010), suggesting that Paf1C
might affect early elongation
indirectly. Regardless of the
exact mechanisms, Bai et al.
(2010) reveal a sophisticated
interplay between multiple
transcription factors, and ex-
pose transcription elongation
as a critical checkpoint during
cell differentiation.REFERENCES
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